BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20332081)

  • 1. Vimentin and desmin possess GlcNAc-binding lectin-like properties on cell surfaces.
    Ise H; Kobayashi S; Goto M; Sato T; Kawakubo M; Takahashi M; Ikeda U; Akaike T
    Glycobiology; 2010 Jul; 20(7):843-64. PubMed ID: 20332081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engulfment and clearance of apoptotic cells based on a GlcNAc-binding lectin-like property of surface vimentin.
    Ise H; Goto M; Komura K; Akaike T
    Glycobiology; 2012 Jun; 22(6):788-805. PubMed ID: 22345628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of vimentin- or desmin-expressing liver cells with N-acetylglucosamine-bearing polymers.
    Kim SJ; Ise H; Goto M; Akaike T
    Biomaterials; 2012 Mar; 33(7):2154-64. PubMed ID: 22177839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidation of GlcNAc-binding properties of type III intermediate filament proteins, using GlcNAc-bearing polymers.
    Ise H; Yamasaki S; Sueyoshi K; Miura Y
    Genes Cells; 2017 Oct; 22(10):900-917. PubMed ID: 28898551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene delivery system based on highly specific recognition of surface-vimentin with N-acetylglucosamine immobilized polyethylenimine.
    Kim SJ; Ise H; Goto M; Komura K; Cho CS; Akaike T
    Biomaterials; 2011 May; 32(13):3471-80. PubMed ID: 21329974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plectin interacts with the rod domain of type III intermediate filament proteins desmin and vimentin.
    Favre B; Schneider Y; Lingasamy P; Bouameur JE; Begré N; Gontier Y; Steiner-Champliaud MF; Frias MA; Borradori L; Fontao L
    Eur J Cell Biol; 2011 May; 90(5):390-400. PubMed ID: 21296452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colocalization of nestin and vimentin/desmin in skeletal muscle cells demonstrated by three-dimensional fluorescence digital imaging microscopy.
    Sjöberg G; Jiang WQ; Ringertz NR; Lendahl U; Sejersen T
    Exp Cell Res; 1994 Oct; 214(2):447-58. PubMed ID: 7925640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The binding in vitro of modified LDL to the intermediate filament protein vimentin.
    Heidenthal AK; Weber PC; Lottspeich F; Hrboticky N
    Biochem Biophys Res Commun; 2000 Jan; 267(1):49-53. PubMed ID: 10623572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of surfactant protein A with the intermediate filaments desmin and vimentin.
    Garcia-Verdugo I; Synguelakis M; Degrouard J; Franco CA; Valot B; Zivy M; Chaby R; Tanfin Z
    Biochemistry; 2008 May; 47(18):5127-38. PubMed ID: 18407667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic behaviors of vimentin induced by interaction with GlcNAc molecules.
    Komura K; Ise H; Akaike T
    Glycobiology; 2012 Dec; 22(12):1741-59. PubMed ID: 22846177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylglucosamine-bearing polymers mimicking O-GlcNAc-modified proteins elicit anti-fibrotic activities in myofibroblasts and activated stellate cells.
    Ise H; Araki Y; Song I; Akatsuka G
    Glycobiology; 2023 Jan; 33(1):17-37. PubMed ID: 36190502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forced expression of desmin and desmin mutants in cultured cells: impact of myopathic missense mutations in the central coiled-coil domain on network formation.
    Bär H; Kostareva A; Sjöberg G; Sejersen T; Katus HA; Herrmann H
    Exp Cell Res; 2006 May; 312(9):1554-65. PubMed ID: 16519886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and structural aspects of transiently and stably expressed mutant desmin in vimentin-free and vimentin-containing cells.
    Raats JM; Gerards WL; Schreuder MI; Grund C; Henderik JB; Hendriks IL; Ramaekers FC; Bloemendal H
    Eur J Cell Biol; 1992 Jun; 58(1):108-27. PubMed ID: 1644057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of vimentin intermediate filaments in transgenic mice by expression of a dominant negative mutant desmin subunit.
    Pieper FR; Raats JM; Schaart G; Dunia I; van der Kemp A; Benedetti EL; Ramaekers FC; Bloemendal H
    Eur J Cell Biol; 1995 Dec; 68(4):355-68. PubMed ID: 8690015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation and characterization of homo and hetero-oligomers of the intermediate filament proteins desmin and vimentin.
    Traub P; Kühn S; Grüb S
    J Mol Biol; 1993 Apr; 230(3):837-56. PubMed ID: 8478938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembly of carboxy-terminally deleted desmin in vimentin-free cells.
    Raats JM; Henderik JB; Verdijk M; van Oort FL; Gerards WL; Ramaekers FC; Bloemendal H
    Eur J Cell Biol; 1991 Oct; 56(1):84-103. PubMed ID: 1724756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins.
    Skalli O; Schürch W; Seemayer T; Lagacé R; Montandon D; Pittet B; Gabbiani G
    Lab Invest; 1989 Feb; 60(2):275-85. PubMed ID: 2644484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct morphological demonstration of the coexistence of vimentin and desmin in the same intermediate filaments of vascular smooth muscle cells.
    Fujimoto T; Tokuyasu KT; Singer SJ
    J Submicrosc Cytol; 1987 Jan; 19(1):1-9. PubMed ID: 3550117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of intermediate filament desmin and vimentin in the human fetal heart.
    Kim HD
    Anat Rec; 1996 Oct; 246(2):271-8. PubMed ID: 8888968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference of amino-terminal desmin fragments with desmin filament formation.
    Bär H; Sharma S; Kleiner H; Mücke N; Zentgraf H; Katus HA; Aebi U; Herrmann H
    Cell Motil Cytoskeleton; 2009 Nov; 66(11):986-99. PubMed ID: 19530175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.